The GO and KEGG enrichment in the Database for Annotation, Visualisation and Integrated Discovery (DAVID) showed the TYTW targeted at stomach neoplasms, malignant neoplasm of the stomach, and hereditary diffuse gastric cancer; GO term enrichment includes protein phosphorylation, protein serine/threonine/tyrosine kinase activity, ATP binding, protein serine/threonine kinase activity, peptidyl-serine phosphorylation, protein kinase activity, and kinase activity (Table 3). The gene discussed is AKT1; the disease is gastric neoplasm.